Growth drivers and resistors of the influenza market: The importance of cell culture flu

Journal of Commercial Biotechnology

Volumn 12, Issue 2, 2006, Pages 150-155

  Belsey, Mark ^a   Evans, David ^a   Pavlou, Alex ^a   Savopoulos, John ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLU VACCINE; INFECTIOUS DISEASE ANALYSIS; INFLUENZA; VACCINE PRODUCTION;

BIOTECHNOLOGY; DISEASES; IMMUNOLOGY; PRODUCTION; VACCINES;

CELL CULTURE;

AVIAN INFLUENZA VACCINE; INFLEXAL; INFLUENZA VACCINE; UNCLASSIFIED DRUG;

ARTICLE; AVIAN INFLUENZA; CELL CULTURE; DRUG MANUFACTURE; GROWTH RATE; HUMAN; INFLUENZA; INFLUENZA VIRUS A H5N1; INTERMETHOD COMPARISON; PANDEMIC; UNITED STATES; VACCINATION; VACCINE PRODUCTION;

AVES; FLU VACCINE;

EID: 34447279088     PISSN: 14628732     EISSN: None     Source Type: Journal    
DOI: 10.1057/palgrave.jcb.3040160     Document Type: Article

References (16)

1. Scuffham, P. A. and West, P. A. (2002), 'Economic evaluation of strategies for the control and management of influenza in Europe', Vaccine, Vol. 20, pp. 2562-2578.
2. URL: http://www.who.int/CST/don/2003_07_03/en
3. URL: http://www.who.int/mediacentre/factsheets/2003/fs2ll/en
4. Cyranoski, D. (2005), 'Threat of pandemic brings flu drug back to life', Nature, Vol. 23(435), p. 1009.
5. Kiso, M., Mitamura, K., Sakai-Tagawa, Y., Shiraishi, K., Kawakami, C., Kimura, K., Hayden, F. G., Sugaya, N. and Kawaoka, Y. (2004), 'Resistant influenza A viruses in children treated with oseltamivir: Descriptive study', Lancet, Vol. 364, pp. 759-765.
6. Stephenson, I. and Nicholson, K. G. (2001), 'Influenza: Vaccination and treatment', Eur. Respir. J., Vol. 17, pp. 1282-1293.
7. URL: www.cdc.gov/nip/ed/vpd2004/vpd04flu-script.rtf
8. URL: http://www.cdc.gov/nip/news/newsltrs/imwrks/2002/200207.htm
9. Medema, J. K., Zoellner, Y. F., Ryan, J. and Palache, A. M. (2004), 'Modeling pandemic preparedness scenarios: Health economic implications of enhanced pandemic vaccine supply', Virus Res., Vol. 103, pp. 9-15.
10. Fedson, D. S. (2003), 'Pandemic influenza and the global vaccine supply', Clin. Infect. Dis., Vol. 36, pp. 1552-1561.
11. URL: http://www.dh.gov.uk/assetRoot/04/12/17/44/04121744.pdf
12. URL: http://appropriations.house.gov/_files/BruceGellinTestimony.pdf
13. URL: http://www.who.int/csr/disease/avian_influenza/ Better_vaccines_better_acess.pdf
14. Govorkova, E. A., Murti, G., Meignier, B., de Taisne, C. and Webster, R. G. (1996), 'African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses', J. Virol., Vol. 70, pp. 5519-5524.
15. Youil, R., Su, Q., Toner, T. J., Szymkowiak, C., Kwan, W. S., Rubin, B., Petrukhin, L., Kiseleva, I., Shaw, A. R. and DiStefano, D. (2004), 'Comparative study of influenza virus replication in Vero and MDCK cell lines', J. Virol. Methods, Vol. 120, pp. 23-31.
16. URL: http://www.who.int/csr/resources/publications/influenza/ whocdscsrncs20025rev.pdf